Update of a phase I/II trial of 5-azacytidine prior to Gemtuzumab Ozogamicin (GO) for patients with relapsed acute myeloid Leukemia with correlative biomarker studies

Category Primary study
JournalBlood
Year 2010
This article has no abstract
Epistemonikos ID: 4ed7eb5c2c1ea02aa0c4c8689629f40abb749f3c
First added on: Feb 05, 2025